Journal profile · Pharmacology & Pharmacy
Phytotherapy Research
ISSN 0951-418X · eISSN 1099-1573 · John Wiley and Sons Ltd · ENGLAND · Monthly · Founded 1987
Phytotherapy Research: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.04; hybrid open access; APC about USD 4,880; median 196 days to acceptance (97 articles, last 24 months); community-reported acceptance: easy; 291 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Phytotherapy Research is published by John Wiley and Sons Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Natural product bioactivities and synthesis, Essential Oils and Antimicrobial Activity and Phytochemistry and Biological Activities, together about 27.2% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Phytotherapy Research is a pharmacology journal for biochemists, pharmacologists, & toxicologists interested in medicinal plant research & clinical applications.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Bee HockinPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology9.8%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences8.9%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences8.5%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics7.7%
- Phytochemicals and Antioxidant ActivitiesMedicine5.9%
- Natural Antidiabetic Agents StudiesMedicine5.1%
- Ginseng Biological Effects and ApplicationsBiochemistry, Genetics and Molecular Biology3.7%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Chemistry, Medicinal | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Chemistry, Medicinal | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Chemistry, Medicinal | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.04LetPub ·
- Impact factor (publisher)
- 8.1Publisher website ·
- CiteScore 2026-06
- 14.5LetPub ·
- CiteScore (publisher)
- 14.5Publisher website ·
- SJR 2026-06
- 1.64LetPub ·
- SNIP 2026-06
- 1.65LetPub ·
- h-index
- 112LetPub ·
- h-index
- 192OpenAlex ·
- i10-index
- 7,079OpenAlex ·
- 2-year mean citedness
- 7.2OpenAlex ·
- Self-citation rate
- 2.5%LetPub ·
- Share of gold OA articles
- 11.87%LetPub ·
Volume
- Articles per year
- 256LetPub ·
Articles by year OpenAlex count · 9,872 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 308 | 138 | 244 |
| 2025 | 291 | 98 | 1,565 |
| 2024 | 339 | 147 | 4,942 |
| 2023 | 390 | 159 | 8,061 |
| 2022 | 368 | 72 | 9,115 |
| 2021 | 370 | 56 | 14,523 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
196 daysMedian, submission to acceptance · P25–P75 135 days – 291 days
- Acceptance to online
- median 16 days (97 articles)
- Submission to online
- median 248 days
- Sample
- 97 articles with submission and acceptance dates (660 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3.2 monthsLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 5%Publisher website ·
- Submission to first decision
- 18 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,880 / EUR 4,030 / GBP 3,300 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1987
- ISSN
- 0951-418X
- Electronic ISSN
- 1099-1573
- Latest issue on the website
- Volume 40, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Phytotherapy Research
What CAS zone is Phytotherapy Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Phytotherapy Research is in Zone 2 of Medicine, and in Zone 2 of the minor category Chemistry, Medicinal / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Phytotherapy Research?
The latest impact factor listed by LetPub is 8.04; CiteScore 14.5, h-index 192.
How long does peer review take at Phytotherapy Research?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 196 days (interquartile range 135–291 days); authors report an average review time of about 3.2 months; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 5%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Phytotherapy Research?
According to LetPub and DOAJ records, Phytotherapy Research is indexed in SCIE and Scopus.
Is Phytotherapy Research open access, and what is the APC?
Phytotherapy Research is a hybrid journal. For open-access publication: APC about USD 4,880.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .